Li Watsek
Stock Analyst at Cantor Fitzgerald
(0.14)
# 4,282
Out of 4,386 analysts
116
Total ratings
34.3%
Success rate
-12.6%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Li Watsek
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SNSE Sensei Biotherapeutics | Maintained: Buy | n/a | $13.00 | - | 2 | Jun 3, 2026 | |
| ZLAB Zai Lab | Maintained: Buy | $37 | $16.48 | +124.51% | 8 | Apr 29, 2026 | |
| REPL Replimune Group | Downgraded: Hold | n/a | $8.97 | - | 5 | Apr 10, 2026 | |
| ASND Ascendis Pharma | Maintained: Buy | $300 | $205.81 | +45.77% | 24 | Apr 1, 2026 | |
| CRIS Curis | Rated: Hold | n/a | $0.4701 | - | 4 | Mar 27, 2026 | |
| TYRA Tyra Biosciences | Maintained: Buy | n/a | $26.75 | - | 2 | Mar 4, 2026 | |
| AVBP ArriVent BioPharma | Initiated Coverage: Buy | n/a | $30.50 | - | 1 | Dec 22, 2025 | |
| CMPX Compass Therapeutics | Initiated Coverage: Buy | n/a | $2.02 | - | 1 | Dec 3, 2025 | |
| RCUS Arcus Biosciences | Reiterated: Buy | n/a | $23.32 | - | 6 | Oct 8, 2025 | |
| CNTX Context Therapeutics | Initiated Coverage: Buy | n/a | $1.71 | - | 1 | Oct 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $7.15 | - | 6 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $31.48 | - | 2 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $8.56 | - | 8 | Jun 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $11.15 | - | 8 | Jun 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.41 | n/a | 3 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0001 | n/a | 3 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $4.04 | n/a | 1 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.57 | n/a | 6 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $4.11 | n/a | 5 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 | $0.2922 | n/a | 4 | Aug 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 | $1.91 | n/a | 5 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $5 | $0.01315 | n/a | 3 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8.37 → $53.00 | $2.20 | n/a | 3 | Jun 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $71 → $38 | $2.40 | n/a | 2 | Aug 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $6 | $7.98 | n/a | 3 | Jun 28, 2022 |
Sensei Biotherapeutics
Jun 3, 2026
Maintained: Buy
Price Target: n/a
Current: $13.00
Upside: -
Zai Lab
Apr 29, 2026
Maintained: Buy
Price Target: $37
Current: $16.48
Upside: +124.51%
Replimune Group
Apr 10, 2026
Downgraded: Hold
Price Target: n/a
Current: $8.97
Upside: -
Ascendis Pharma
Apr 1, 2026
Maintained: Buy
Price Target: $300
Current: $205.81
Upside: +45.77%
Curis
Mar 27, 2026
Rated: Hold
Price Target: n/a
Current: $0.4701
Upside: -
Tyra Biosciences
Mar 4, 2026
Maintained: Buy
Price Target: n/a
Current: $26.75
Upside: -
ArriVent BioPharma
Dec 22, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $30.50
Upside: -
Compass Therapeutics
Dec 3, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $2.02
Upside: -
Arcus Biosciences
Oct 8, 2025
Reiterated: Buy
Price Target: n/a
Current: $23.32
Upside: -
Context Therapeutics
Oct 2, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $1.71
Upside: -
Sep 18, 2025
Reiterated: Buy
Price Target: n/a
Current: $7.15
Upside: -
Sep 9, 2025
Reiterated: Buy
Price Target: n/a
Current: $31.48
Upside: -
Jun 26, 2025
Reiterated: Buy
Price Target: n/a
Current: $8.56
Upside: -
Jun 12, 2025
Reiterated: Buy
Price Target: n/a
Current: $11.15
Upside: -
May 15, 2025
Reiterated: Buy
Price Target: n/a
Current: $1.41
Upside: n/a
May 14, 2025
Downgraded: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Mar 14, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $4.04
Upside: n/a
Jan 24, 2025
Reiterated: Buy
Price Target: n/a
Current: $1.57
Upside: n/a
Jun 3, 2024
Reiterated: Buy
Price Target: n/a
Current: $4.11
Upside: n/a
Aug 30, 2023
Maintained: Buy
Price Target: $11
Current: $0.2922
Upside: n/a
Aug 9, 2023
Reiterated: Hold
Price Target: $5
Current: $1.91
Upside: n/a
Aug 7, 2023
Reiterated: Buy
Price Target: $8 → $5
Current: $0.01315
Upside: n/a
Jun 11, 2023
Reiterated: Buy
Price Target: $8.37 → $53.00
Current: $2.20
Upside: n/a
Aug 12, 2022
Maintained: Buy
Price Target: $71 → $38
Current: $2.40
Upside: n/a
Jun 28, 2022
Maintained: Buy
Price Target: $16 → $6
Current: $7.98
Upside: n/a